Stephanie Krebs's Insider Trades & SAST Disclosures

Stephanie Krebs's most recent trade in Sensei Biotherapeutics Inc was a trade of 120,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 14, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Sensei Biotherapeutics Inc
Stephanie Krebs Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Feb 2025 120,000 120,000 - - Stock Option (Right to Buy)
Sensei Biotherapeutics Inc
Stephanie Krebs Chief Business Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Dec 2024 120,000 120,000 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades